Search Results for:

More financial services companies are taking up the challenge of measuring the carbon footprint of their investments
No Date

In this blog from our Privately Speaking series, KPMG Private Enterprise Life Sciences leader, Janet Lehman, talks about healthtech startups and why they are at the very top of every venture capital (VC) investor’s list. Can the trend last?
No Date

Learn about SPACs and how private company leaders and their boards can leverage this potential growth opportunity.
No Date

Explore high-level results from this year’s U.S. CEO Outlook and discover how leading organizations are dealing with the implications of COVID-19.
No Date

A guide for entrepreneurs, to inspire and empower their journey.
No Date

Information for business leaders as they take their companies to the next level.
No Date

Road to New Reality – How to protect revenue and focus on innovation in a time of COVID-19.
No Date

Nine key issues that we believe private company boards should be considering as they develop and execute on their 2021 agendas.
No Date

Explore some of the key opportunities and challenges in the evolving SPAC market.
No Date

Explore the trends that shaped the IPO and M&A landscape in the first half of 2020 and find out what’s in store for the remainder of the year.
No Date

Join KPMG Private Enterprise professionals as they examine the activity and trends that shaped the VC investment landscape and share their insights for 2021.
No Date

Improving information flow to improve operations
No Date

Five key areas private company boards should be focusing on in the coming months.
No Date

Explore first-quarter venture capital (VC) market results to find out how companies and investors responded to the immediate impact of COVID-19.
No Date

Discover how private company leaders can encourage more innovative thinking to drive resilience and recovery during a crisis.
No Date